Shamburg News · 8-K filed Oct 23, 2026, 4:05 PM EDT
Aptevo Therapeutics Amends Rights Agreement, Extending Expiration to October 23, 2027
APVO · Aptevo Therapeutics Inc.
- Material agreement
- Other
- Materiality: low
On October 23, 2026, Aptevo Therapeutics Inc. entered into Amendment No. 6 to its Rights Agreement with Broadridge Corporate Issuer Solutions, LLC, as rights agent. The amendment extends the Final Expiration Date to October 23, 2027 and changes the Purchase Price to $14.56 per one one-thousandth of a Series A Junior Participating Preferred Share. The amendment is filed as Exhibit 4.1.
Source: SEC EDGAR, Form 8-K, Items 1.01, 3.03, 9.01, accession 0001193125-26-430419.
Written from the filing by Shamburg Markets. Figures are as reported by the company.